Human antibodies that bind human TNFα

  • US 7,223,394 B2
  • Filed: 03/07/2001
  • Issued: 05/29/2007
  • Est. Priority Date: 02/09/1996
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method for treating a subject suffering from rheumatoid arthritis, comprising administering to the subject both an antibody and methotrexate, such that the rheumatoid arthritis is treated, wherein the antibody is an isolated human antibody, or an antigen-binding portion thereof, tat dissociates from human TNFα

  • with a Kd of 1×

    10

    8
    M or less and a Koff rate constant of 1×

    10

    3
    s

    1
    or less, both determined by surface plasmon resonance, and neutralizes human TNFα

    cytotoxicity in a standard in vitro L929 assay with an IC50 of 1×

    10

    7
    M or less.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×